Agilent Technologies Stock Forecast, Price & News

26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 7 hold ratings and 19 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Agilent Technologies stock.
View analyst ratings for Agilent Technologies or view top-rated stocks.

Wall Street analysts have given Agilent Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Agilent Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Agilent Technologies is scheduled to release its next quarterly earnings announcement on Thursday, May 20th 2021.
View our earnings forecast for Agilent Technologies.

Agilent Technologies, Inc. (NYSE:A) announced its quarterly earnings results on Monday, February, 15th. The medical research company reported $1.06 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.89 by $0.17. The medical research company earned $1.55 billion during the quarter, compared to analysts' expectations of $1.43 billion. Agilent Technologies had a net margin of 13.47% and a trailing twelve-month return on equity of 21.02%. During the same quarter last year, the company earned $0.81 earnings per share.
View Agilent Technologies' earnings history.

Agilent Technologies' stock was trading at $68.84 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, A stock has increased by 94.5% and is now trading at $133.88.
View which stocks have been most impacted by COVID-19.

Agilent Technologies announced a quarterly dividend on Wednesday, March 17th. Shareholders of record on Tuesday, April 6th will be paid a dividend of $0.194 per share on Wednesday, April 28th. This represents a $0.78 annualized dividend and a yield of 0.58%. The ex-dividend date is Monday, April 5th.
View Agilent Technologies' dividend history.

Agilent Technologies pays an annual dividend of $0.78 per share and currently has a dividend yield of 0.58%. Agilent Technologies does not yet have a strock track record of dividend growth. The dividend payout ratio of Agilent Technologies is 23.78%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Agilent Technologies will have a dividend payout ratio of 18.80% next year. This indicates that Agilent Technologies will be able to sustain or increase its dividend.
View Agilent Technologies' dividend history.

Agilent Technologies announced that its board has authorized a stock buyback plan on Tuesday, February 16th 2021, which permits the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 5% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's management believes its shares are undervalued.

Agilent Technologies updated its FY 2021 After-Hours earnings guidance on Tuesday, February, 16th. The company provided EPS guidance of 3.80-3.90 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.71. The company issued revenue guidance of $5.825-5.9 billion, compared to the consensus revenue estimate of $5.75 billion.

26 equities research analysts have issued 1-year target prices for Agilent Technologies' shares. Their forecasts range from $30.70 to $150.00. On average, they anticipate Agilent Technologies' stock price to reach $106.19 in the next year. This suggests that the stock has a possible downside of 20.7%.
View analysts' price targets for Agilent Technologies or view top-rated stocks among Wall Street analysts.

452 employees have rated Agilent Technologies CEO Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among Agilent Technologies' employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Agilent Technologies include Thermo Fisher Scientific (TMO), Illumina (ILMN), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), Waters (WAT), Charles River Laboratories International (CRL), Bio-Techne (TECH), PerkinElmer (PKI), Bruker (BRKR), Pacific Biosciences of California (PACB), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD).
View all of A's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), The Boeing (BA) and Skyworks Solutions (SWKS).

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Royal London Asset Management Ltd. (0.63%), LGT Capital Partners LTD. (0.28%), Clarus Group Inc. (0.16%), Calamos Advisors LLC (0.08%), Raub Brock Capital Management LP (0.07%) and DnB Asset Management AS (0.05%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Mark Doak, Michael R Mcmullen, Michael Tang, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends for Agilent Technologies.

A stock was sold by a variety of institutional investors in the last quarter, including BOKF NA, Sentry Investment Management LLC, State of Alaska Department of Revenue, DnB Asset Management AS, Hexavest Inc., Retirement Systems of Alabama, Baldwin Brothers Inc. MA, and Boston Trust Walden Corp. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Dominique Grau, Heidi Fields, Michael R Mcmullen, Michael Tang, Rodney Gonsalves, and Samraat S Raha.
View insider buying and selling activity for Agilent Technologies or view top insider-selling stocks.

A stock was bought by a variety of institutional investors in the last quarter, including Clarus Group Inc., Raub Brock Capital Management LP, LGT Capital Partners LTD., MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH, Exchange Traded Concepts LLC, Everence Capital Management Inc., Royal London Asset Management Ltd., and Oregon Public Employees Retirement Fund.
View insider buying and selling activity for Agilent Technologies or or view top insider-buying stocks.

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of A stock can currently be purchased for approximately $133.88.

Agilent Technologies has a market capitalization of $40.79 billion and generates $5.34 billion in revenue each year. The medical research company earns $719 million in net income (profit) each year or $3.28 on an earnings per share basis.

Agilent Technologies employs 16,400 workers across the globe.

The following companies are subsidiares of Agilent Technologies: ACEA BIO, AT Singapore (Global) Pte Ltd., ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Rhone AG, Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako ApS, Dako Denmark, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.

Agilent Technologies was founded in 1999.

The official website for Agilent Technologies is www.agilent.com.

Agilent Technologies is headquartered at 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at (800) 227-9770 or via email at [email protected]